These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

147 related items for PubMed ID: 2472515

  • 1. Bolus injections of synthetic atrial natriuretic peptide in patients with chronic renal failure or nephrotic syndrome.
    Burnier M, Mooser V, Wauters JP, Marder HK, De Vane P, Nussberger J, Waeber B, Brunner HR.
    J Cardiovasc Pharmacol; 1989 May; 13(5):682-90. PubMed ID: 2472515
    [Abstract] [Full Text] [Related]

  • 2. Atrial natriuretic peptide, sodium retention, and proteinuria in nephrotic syndrome.
    Plum J, Mirzaian Y, Grabensee B.
    Nephrol Dial Transplant; 1996 Jun; 11(6):1034-42. PubMed ID: 8671965
    [Abstract] [Full Text] [Related]

  • 3. Plasma concentration and renal effect of human atrial natriuretic peptide in nephrotic syndrome.
    Hisanaga S, Yamamoto Y, Kida O, Kato J, Fujimoto S, Tanaka K.
    Nihon Jinzo Gakkai Shi; 1989 Jun; 31(6):661-9. PubMed ID: 2529385
    [Abstract] [Full Text] [Related]

  • 4. Regulation of renal sodium and water excretion in the nephrotic syndrome and cirrhosis of the liver.
    Jespersen B.
    Dan Med Bull; 1997 Apr; 44(2):191-207. PubMed ID: 9151012
    [Abstract] [Full Text] [Related]

  • 5. Renal and hemodynamic effects of synthetic atrial natriuretic peptide in dogs with chronic renal failure.
    Tsuchiya K, Sanaka T, Ando A.
    Nihon Jinzo Gakkai Shi; 1989 Feb; 31(2):151-7. PubMed ID: 2525634
    [Abstract] [Full Text] [Related]

  • 6. C-type natriuretic peptide in chronic renal failure and its action in humans.
    Igaki T, Itoh H, Suga S, Hama N, Ogawa Y, Komatsu Y, Mukoyama M, Sugawara A, Yoshimasa T, Tanaka I, Nakao K.
    Kidney Int Suppl; 1996 Jun; 55():S144-7. PubMed ID: 8743538
    [Abstract] [Full Text] [Related]

  • 7. Effects of atrial natriuretic peptide versus mannitol on renal blood flow during radiocontrast infusion in chronic renal failure.
    Kurnik BR, Weisberg LS, Cuttler IM, Kurnik PB.
    J Lab Clin Med; 1990 Jul; 116(1):27-36. PubMed ID: 2142949
    [Abstract] [Full Text] [Related]

  • 8. Physiologic role and diuretic efficacy of atrial natriuretic peptide in health and chronic renal disease.
    Conte G, Bellizzi V, Cianciaruso B, Minutolo R, Fuiano G, De Nicola L.
    Kidney Int Suppl; 1997 Jun; 59():S28-32. PubMed ID: 9185100
    [Abstract] [Full Text] [Related]

  • 9. Systemic and renal effects of atrial natriuretic peptide in patients with heart failure treated with angiotensin-converting enzyme inhibitor or in acute saline solution loading.
    Tomiyama H, Watanabe G, Abe M, Okazaki R, Yoshida H, Doba N.
    Am Heart J; 2001 Mar; 141(3):422-7. PubMed ID: 11231440
    [Abstract] [Full Text] [Related]

  • 10. Cardiovascular and renal effects of low-dose atrial natriuretic peptide in compensated cirrhosis.
    La Villa G, Lazzeri C, Pascale A, Sestini S, Bisi G, Sciagrà R, Vecchiarino S, Raggi VC, Barletta G, Laffi G, Gentilini P.
    Am J Gastroenterol; 1997 May; 92(5):852-7. PubMed ID: 9149200
    [Abstract] [Full Text] [Related]

  • 11. Renal response to atrial natriuretic peptide in nephrotic syndrome.
    Rabelink AJ, Koomans HA, Gaillard CA, Dorhout Mees EJ.
    Nephrol Dial Transplant; 1987 May; 2(6):510-4. PubMed ID: 2964567
    [Abstract] [Full Text] [Related]

  • 12. Effects of atrial natriuretic peptide at a low dose on water and electrolyte metabolism during general anesthesia.
    Koda M, Sakamoto A, Ogawa R.
    J Clin Anesth; 2005 Feb; 17(1):3-7. PubMed ID: 15721722
    [Abstract] [Full Text] [Related]

  • 13. Human atrial natriuretic peptide: plasma levels, hemodynamic, hormonal, and renal effects in patients with severe congestive heart failure.
    Riegger GA, Kromer EP, Kochsiek K.
    J Cardiovasc Pharmacol; 1986 Feb; 8(6):1107-12. PubMed ID: 2434734
    [Abstract] [Full Text] [Related]

  • 14. Plasma and urinary digitalis-like substance levels during atrial natriuretic peptide infusion in essential hypertensive patients.
    Baldoncini R, Ferri C, Bellini C, Desideri G, De Angelis C, Santucci A.
    Clin Invest Med; 1996 Feb; 19(1):13-9. PubMed ID: 8868311
    [Abstract] [Full Text] [Related]

  • 15. Restoration of renal responsiveness to atrial natriuretic peptide in experimental nephrotic syndrome by albumin infusion.
    Abassi Z, Weissman I, Karram T, Goltsman I, Hoffman A, Better OS, Winaver J.
    Am J Nephrol; 2013 Feb; 38(4):292-9. PubMed ID: 24080549
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. [Acute changes in the hemodynamic profile and circulating levels of atrial natriuretic peptide induced by dobutamine in severe heart failure].
    La Vecchia L, Bottero M, Centofante P, Bedogni F, Ometto R, Cera A, Fortunato A.
    G Ital Cardiol; 1996 Aug; 26(8):863-74. PubMed ID: 9005168
    [Abstract] [Full Text] [Related]

  • 20. Role of angiotensin II in the renal response to atrial natriuretic peptide in normal subjects.
    Rakugi H, Ogihara T, Nakamaru M, Saito H, Shima J, Sakaguchi K, Kumahara Y.
    J Cardiovasc Pharmacol; 1989 Aug; 13 Suppl 6():S55-8. PubMed ID: 2473352
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.